Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1
Clinical trial NCT04795713 · TERMINATED
Trial details
- NCT number
- NCT04795713
- Sponsor
- Molecular Templates, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2024-10-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.